Clinical trials
Recruiting Phase 1/2 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrowhead Pharmaceuticals | 2 |
| Vanderbilt University Medical Center | 2 |
| Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics | 1 |
| Alnylam Pharmaceuticals | 1 |
| Chang Gung Memorial Hospital | 1 |
| China-Japan Friendship Hospital | 1 |
| Chulalongkorn University | 1 |
| Fudan University | 1 |
| Gubra A/S | 1 |
| Hangzhou Sciwind Biosciences Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 21 |
| Overweight | 5 |
| Metabolic Syndrome | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Cognitive Dysfunction | 1 |
| Diabetes Mellitus | 1 |
| Dyslipidemias | 1 |
| Hypertension | 1 |
| Hypertension, Pulmonary | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.